Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism in Patients With Prostate Cancer: Orchiectomy vs. Triptorelin

NCT02102646 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT02102646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02102646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism in Patients With Prostate Cancer: Orchiectomy vs. Triptorelin
Lead sponsor
Herlev Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
October 31, 2015
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, hypogonadism, metabolic syndrome, prostate cancer